Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

cenicriviroc MeSH Supplementary Concept Data 2025


MeSH Supplementary
cenicriviroc
Unique ID
C506967
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C506967
Entry Term(s)
(-)-8-(4-(2-butoxyethoxy)phenyl)-1-isobutyl-n-(4-(((1-propyl-1H-imidazol-5-yl)methyl)sulfinyl)phenyl)-1,2,3,4-tetrahydro-1-benzazocine-5-carboxamide
8-(4-(2-butoxyethoxy)phenyl)-1,2,3,4-tetrahydro-1-(2-methylpropyl)-N-(4-((S)-((1-propyl-1H-imidazol-5-yl)methyl)sulfinyl)phenyl)-1-benzazocine-5-carboxamide
TAK 652
TAK-652
TBR 652
TBR-652
TBR652
Pharm Action
CCR5 Receptor Antagonists
Registry Numbers
15C116UA4Y
0
Heading Mapped to
*Imidazoles
*Sulfoxides
Frequency
52
Note
an inhibitor of HIV-1
Source
Antimicrob Agents Chemother. 2005 Nov;49(11):4584-91
Indexing Information
Receptors, CCR2
Date of Entry
2006/01/13
Revision Date
2020/11/23
cenicriviroc Preferred
TBR 652 Narrower
TAK-652 Narrower
page delivered in 0.005s